QOL Medical, LLC announced that the U.S. Food and Drug Administration has approved the company’s wholly owned manufacturing facility in Clearwater, Florida to manufacture sacrosidase, the drug substance used to make Sucraid® (sacrosidase) Oral Solution.   The Sucraid® drug shortage has been resolved, and this FDA approval eliminates the need for informed consents, assents, physician acknowledgments, and patient questionnaires for all Sucraid® prescriptions. Sucraid® is now available as ...